Aprecia Pharmaceuticals Co — Form D/A

Aprecia Pharmaceuticals Co of LANGHORNE, PA, a company, filed a Form D amendment with the SEC on 2013-12-10. The offering totals $36.3M, of which $14.9M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Etienne A PeroldDirectorPennington, NJ
DAVID A FURNISSExecutive OfficerCINCINNATI, OH
MICHAEL A ROHLFSExecutive OfficerWEST CHESTER, OH
DONALD A WETHERHOLDExecutive OfficerLOVELAND, OH
ROBERT A WILLIFORDExecutive OfficerCINCINNATI, OH
Michael KingExecutive OfficerROAD TOWN, TORTOLA, D8
Etienne Thomas PeroldDirectorPennington, NJ
Michael Thomas RolhfsExecutive OfficerBlue Ash, OH
David Thomas FurnissExecutive OfficerMason, OH
Robert Thomas WillifordExecutive OfficerBlue Ash, OH
James Thomas EvansDirectorCincinnati, OH
Lawrence Thomas GlassmannDirectorBlue Ash, OH
Lawrence Thomas GlassmannExecutive OfficerBlue Ash, OH
E Thomas AringtonDirectorMason, OH
E Thomas AringtonExecutive OfficerMason, OH
Donald Thomas WetherholdExecutive OfficerBlue Ash, OH
Jonathan Thomas LeffDirectorNew York, NY
Michael Thomas RohlfsExecutive OfficerWest Chester, OH
Etienne A PeroldExecutive OfficerPennington, NJ
Glenn S VraniakExecutive OfficerManalapan, NJ
Michael S KingExecutive OfficerPrinceton, NJ
Donald C MonkhouseExecutive OfficerRadnor, PA
Don S WetherholdExecutive OfficerLoveland, OH
Michael C KingExecutive OfficerPrinceton, NJ
Lawrence C GlassmannDirectorCincinnati, OH

Other filings by this issuer (11)

FiledFormOfferingSold
2016-01-28D$84.0M$79.0M
2015-08-31D$52.0M$38.8M
2013-12-09D$36.2M$14.9M
2012-11-19D$8.6M$4.0M
2011-11-04D$25.7M$25.7M
2010-12-20D/A$4.9M$3.9M
2010-11-08D/A$455K$455K
2010-10-18D$105K$105K
2010-01-25D/A$5.5M$5.5M
2009-12-24D$2.5M$2.5M
2009-05-29D$500K$500K

More